Disproportionate loss of CA4 parvalbumin-immunoreactive interneurons in patients with Ammon's horn sclerosis

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 9, 1997, Pages 988-998

  Zhu, Zhen Qing ^a   Armstrong, Dawna L ^a   Hamilton, Winifred J ^a   Grossman, Robert G ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Calcium binding proteins; Epilepsy; Hippocampus; Parvalbumin; Temporal lobe

Indexed keywords

ADULT; ARTICLE; AUTOPSY; CELL LOSS; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DENDRITE; DENTATE GYRUS; FEMALE; GRANULE CELL; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; INTERNEURON; INTRACTABLE EPILEPSY; MAJOR CLINICAL STUDY; MALE; NERVE ENDING; PELIZAEUS MERZBACHER DISEASE; PERIKARYON; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; TEMPORAL LOBECTOMY; ADOLESCENT; CELL COUNT; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; SCLEROSIS; TEMPORAL LOBE EPILEPSY;

PARVALBUMIN;

ADOLESCENT; ADULT; CELL COUNT; EPILEPSY, COMPLEX PARTIAL; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERNEURONS; MALE; MIDDLE AGED; PARVALBUMINS; PYRAMIDAL CELLS; SCLEROSIS;

EID: 0030612034     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199709000-00004     Document Type: Article

References (45)

1. Armstrong DL, Bruton CJ. Postscript: What terminology is appropriate for tissue pathology? How does it predict outcome? In: Engel J Jr. Surgical treatment of the epilepsies. New York: Raven Press, 1987:541-52
2. Duncan JS, Sagar HJ. Seizure characteristics, pathology, and outcome after temporal lobectomy. Neurology 1987;37:405-9
3. Margerison JH, Corsellis JAN. Epilepsy and the temporal lobes: A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain 1966;89:499-530
4. Pasquier B, Bost F, Peoch M, Barnoud R, Pasquier D. Neuropathological findings in resective surgery for medically-intractable epilepsy: A study of 195 cases. Ann Pathol 1996;16:174-81
5. Wolf HK, Campos MG, Zentner J, et al. Surgical pathology of temporal lobe epilepsy: Experience with 216 cases. J Neuropathol Exp Neural 1993;52:499-506
6. de Lanerolle NC, Brines M, Williamson A, Kim JH, Spencer DD. Neurotransmitters and their receptors in human temporal lobe epilepsy. Epilepsy Res 1992;7(suppl):235-50
7. Kim JH, Guimaraes PO, Shen MY, Masukawa LM, Spencer DD. Hippocampal neuronal density in temporal lobe epilepsy with and without gliomas. Acta Neuropathol (Berl) 1990;80:41-45
8. Sloviter RS, Sollas AL, Barbara NM, Laxer KD. Calcium-binding protein (calbindin-D28K) and parvalbumin immunocytochemistry in the normal and epileptic human hippocampus. J Comp Neurol 1991;308:381-96
9. Heizmann C, Braun K. Changes in Ca(2+)-binding proteins in human neurodegenerative disorders. Trends Neurosci 1992;15:259-64
10. Griffiths T, Evans MC, Meldrum BS. Intracellular sites of early calcium accumulation in the rat hippocampus during status epilepticus. Neurosci Lett 1982;30:329-34
11. Freund TF, Ylinen A, Miettinen R, et al. Pattern of neuronal death in the rat hippocampus after status epilepticus: Relationship to calcium binding protein content and ischemic vulnerability. Brain Res Bull 1992;28:27-38
12. Meldrum BS. Metabolic effects of prolonged epileptic seizures and the causation of epileptic brain damage. In: Rose FC. Metabolic disorders of the nervous system. London: Pitman, 1981:175-87
13. Celio MR. Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience 1990;35:375-475
14. Blumcke I, Beck H, Kitsch R, et al. Preservation of calretinin-immunoreactive neurons in the hippocampus of epilepsy patients with Ammons horn sclerosis. J Neuropathol Exp Neurol 1996;55: 329-41
15. Nitsch R, Ohm TG. Calretinin immunoreactive structures in the human hippocampal formation. J Comp Neurol 1995;360:475-87
16. Scharfman HE, Schwartzkroin PA. Protection of dentate hilar cells from prolonged stimulation by intracellular calcium chelation. Science 1989;246:257-60
17. Leranth C, Ribak CE. Calcium-binding proteins are concentrated in the CA2 field of the monkey hippocampus: A possible key to this region's resistance to epileptic damage. Exp Brain Res 1991; 85:129-36
18. Braak E, Strotkamp B, Braak H. Parvalbumin-immunoreactive structures in the hippocampus of the human adult. Cell Tissue Res 1991;264:33-48
19. Nitsch R, Soriano E, Frotscher M. The parvalbumin-containing nonpyramidal neurons in the rat hippocampus. Anat Embryol (Berl) 1990;181:413-25
20. Seress L, Gulyas AI, Ferrer I, Tunon T, Soriano E, Freund TF. Distribution, morphological features, and synaptic connections of parvalbumin- and calbindin D28k-immunoreactive neurons in the human hippocampal formation. J Comp Neurol 1993;337: 208-30
21. Marco P, DeFelipe J. Altered synaptic circuitry in the human temporal neocortex removed from epileptic patients. Expl Brain Res 1997;114:1-10
22. Zhu Z, Armstrong DL, Grossman RG, Hamilton WJ. Tyrosine hydroxylase-immunoreactive neurons in the temporal lobe in complex partial seizures. Ann Neurol 1990;27:564-72
23. Armstrong DL, Grossman RG, Zhu Z. Complex partial epilepsy: Evidence of a malformative process in the resected anterior temporal lobes of thirty-three patients. J Neuropathol Exp Neurol 1990; 46:359
24. Grossman RG, Hamilton WJ. Temporal lobe operations for drug-resistant epilepsy. In: Schmidek HH, Sweet WH. Operative neurosurgical techniques: Indications, methods, and results, 3rd ed. Philadelphia: W. B. Saunders Company, 1995;2:1287-94
25. Hsu SM, Raine L. The use of avidin-biotin-peroxidase complex (ABC) in diagnostic and research pathology. In: DeLellis RA. Advances in immunohistochemistry. New York: Masson, 1984:31-42
26. Mathern GW, Babb TL, Mischel PS, et al. Childhood generalized and mesial temporal epilepsies demonstrate different amounts and patterns of hippocampal neuron loss and mossy fibre synaptic reorganization. Brain 1996;119:965-87
27. Mayhew TM. A review of recent advances in stereology for quantifying neural structure. J Neurocytol 1992;21:313-28
28. Clarke PG. An unbiased correction factor for cell counts in histological sections. J Neurosci Methods 1993;49:133-40
29. Clarke PG. How inaccurate is the Abercrombie correction factor for cell counts? Trends Neurosci 1992;15:211-12
30. Vinters HV, Armstrong DL, Babb TL, et al. The neuropathology of human symptomatic epilepsy. In: Engel J Jr. Surgical treatment of the epilepsies, 2nd ed. New York: Raven Press, 1993:593-608
31. Cajal SR. Histologie du système nerveux de l'homme & des vertébrés. Madrid: Instituto Ramon y Cajal, 1955:733-61
32. DeFelipe J, Jones EG. Cajal on the Cerebral Cortex. An annotated translation of the complete writings. New York/Oxford: Oxford University Press, 1988:580-82
33. Ferrer I, Oliver B, Russi A, Casas R, Rivera R. Parvalbumin and calbindin-D28k immunocytochemistry in human neocortical epileptic foci. J Neurol Sci 1994;123:18-25
34. Marco P, Sola RG, Pulido P, et al. Inhibitory neurons in the human epileptogenic temporal neocortex: An immunocytochemical study. Brain 1996;119:1327-47
35. Angevine JB Jr. Time of neuron origin in the hippocampal region: An autoradiographic study in the mouse. Exp Neurol 1965;2(suppl 2):1-70
36. Bayer SA, Altman J, Russo RJ, Zhang X. Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 1993;14:83-144
37. Berger B, Alvarez C. Neurochemical development of the hippocampal region in the fetal rhesus monkey. 3. Calbindin-d28k, calretinin and parvalbumin with special mention of cajal-retzius cells and the retrosplenial cortex. J Comp Neurol 1996;366:674-99
38. Tortosa A, Ferrer I. Poor correlation between delayed neuronal death induced by transient forebrain ischemia, and immunoreactivity for parvalbumin and calbindin D-28k in developing gerbil hippocampus. Acta Neuropathol 1994;88:67-74
39. Nitsch R, Bergmann I, Kuppers K, Mueller G, Frotscher M. Late appearance of parvalbumin-immunoreactivity in the development of GABAergic neurons in the rat hippocampus. Neurosci Lett 1990; 118:147-50
40. Scheibel ME, Scheibel AB. Hippocampal pathology in temporal lobe epilepsy: A Golgi survey. In: Brazier MAB. Epilepsy: Its phenomena in man, ed. New York: Academic Press, 1973:315-40
41. Jacobs KM, Gutnick MJ, Prince DA. Hyperexcitability in a model of cortical maldevelopment. Cerebral Cortex 1996;6:514-23
42. Freund TF, Gulyas AI, Acsady L, Gores T, Toth K. Serotonergic control of the hippocampus via local inhibitory interneurons. Proc Natl Acad Sci USA 1990;87:8501-5
43. Kiss J, Buzsaki G, Morrow JS, Glantz SB, Leranth C. Entorhinal cortical innervation of parvalbumin-containing neurons (basket and chandelier cells) in the rat Ammon's horn. Hippocampus 1996;6: 239-46
44. Martinez A, Lubke J, Delrio JA, Soriano E, Frotscher M. Regional variability and postsynaptic targets of chandelier cells in the hippocampal formation of the rat. J Comp Neurol 1996;376:28-44
45. Ribak CE, Seress L, Leranth C. Electron microscopic immunocytochemical study of the distribution of parvalbumin-containing neurons and axon terminals in the primate dentate gyrus and Ammon's horn. J Comp Neural 1993;327:298-321